Delibere
Seduta del 24/05/2017
Delibera del 23 Maggio, n. 285 [file.pdf]
Approvazione Emendamento sostanziale n.1 riguardante La Sperimentazione dal titolo “A phase III randomized, double blind, placebo controlled study of BKM120 with fulvestrant, in postmenopausal women with hormone receptor - positive HER2-negative AI treated, locally advanced or metastatic breast cancer who progressed on or after mTOR inhibitor based treatment.
Approvazione Emendamento sostanziale n.1 riguardante La Sperimentazione dal titolo “A phase III randomized, double blind, placebo controlled study of BKM120 with fulvestrant, in postmenopausal women with hormone receptor - positive HER2-negative AI treated, locally advanced or metastatic breast cancer who progressed on or after mTOR inhibitor based treatment.
In pubblicazione dal: 24/05/2017-al: 08/06/2017